Popis: |
Abstract Background Despite the known efficacy of colorectal cancer (CRC) screening, the rates of individuals undergoing such testing have remained lower than target thresholds, even prior to the healthcare disruptions associated with the COVID‐19 pandemic. We evaluated the impact of the COVID‐19 pandemic on CRC screening within a nationally representative US population and assessed disparities in screening across racial/ethnic groups and socioeconomic (SES) strata. Methods We performed a retrospective cross‐sectional study using all eligible TRICARE beneficiaries aged 45–64 years between FY 2018 and 2021. High‐risk individuals, those with a previous or current CRC diagnosis, and/or a personal/family history of colonic polyps, were excluded. The pre‐COVID‐19 period (September 1, 2018–March 31, 2020) was compared to the COVID‐19 period (April 1, 2020–September 30, 2021). Secondary analyses were performed, evaluating the interaction between the COVID‐19 time period, race, and our proxy for socioeconomic status. Results During the study period, we identified 1,749,688 eligible individuals. Following the onset of the COVID‐19 pandemic, CRC screening overall decreased from 34% in the pre‐pandemic period to 30% following the onset of the pandemic (p |